Last updated: May 7, 2024
Sponsor: University Hospital, Bordeaux
Overall Status: Completed
Phase
N/A
Condition
Perimenopause
Treatment
Questionnaire
Clinical Study ID
NCT06228547
CHUBX 2023/24
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- woman aged 18 years and older,
- diagnosed with POI following ESHRE 2016 criteria,
- speaking and reading French language,
- woman's oral consent,
- affiliated or beneficiary of health insurance.
Exclusion
Exclusion Criteria:
- iatrogenic POI (surgery, radiotherapy, chemotherapy linked),
- chromosomic POI (Turner Syndrome),
- inability for the woman to understand the nature or risks or significance andimplications of the study,
- woman under legal protection
Study Design
Total Participants: 101
Treatment Group(s): 1
Primary Treatment: Questionnaire
Phase:
Study Start date:
July 26, 2023
Estimated Completion Date:
April 19, 2024
Study Description
Connect with a study center
CHU Bordeaux
Bordeaux,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.